Research programme: radiolabelled carbonic anhydrase IX inhibitors - Progenics Pharmaceuticals

Drug Profile

Research programme: radiolabelled carbonic anhydrase IX inhibitors - Progenics Pharmaceuticals

Alternative Names: 99mTc-MIP-1505; 99mTc/Re(CO)3 labelled benzenesulfonamide conjugates for molecular imaging of carbonic anhydrase IX - Progenics; Hypoxia-imaging radiopharmaceutical - Progenics; MIP-1267; MIP-1505; Small molecular inhibitor of CA IX radiolabelled with 99mTc - Progenics; Small-molecule benzenesulfonamide (BzSA) CA-IX inhibitors - Progenics

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Molecular Insight Pharmaceuticals
  • Class Benzene derivatives; Radiopharmaceutical diagnostics; Small molecules; Sulfonamides
  • Mechanism of Action Carbonic anhydrase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Solid-tumours(Diagnosis) in USA
  • 22 Jan 2013 Molecular Insight Pharmaceuticals has been acquired by Progenics Pharmaceuticals
  • 23 Aug 2012 Pharmacodynamics data from a preclinical trial in Solid tumours (diagnosis of tumour hypoxia) presented at the 244th American Chemical Society National Meeting (244th-ACS-2012)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top